Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Suffix Smackdown: Gottlieb Calls Issue 'Red Herring' For Biosimilars

19 Jul 2018

• By Derrick Gingery

the word suffix on cubes

Related Content

Biologics Naming: US FDA Ponders How To Put New System In Place, While WHO Puts Hold On Pilot Study

27 Oct 2017

Biological Product Suffix Submissions Limited To 10 Candidates By US FDA

16 Jan 2017

USP Backs Down From Biologic Monograph Naming Plan Amid US FDA Objections

01 May 2018

With Biosimilar Statistical Guidance Withdrawn, Expect Sponsor-Specific Advice, FDA's Christl Says

26 Jun 2018

Industry May Like FDA's Biosimilar Guidance Withdrawal, But Not The New Information Vacuum

22 Jun 2018

First Three Novel Biologic Suffixes Came Courtesy Of US FDA, Not Sponsors

27 Jan 2018

US FDA Likely Not 'Significant', Could Be Mostly Spared From Trump's Regulation-Slashing Order

10 Feb 2017

FDA’s Burden Estimate On Biologic Naming Ignores Downstream Costs, Critics Say

16 Feb 2017

From Random To Meaningful: The Evolution Of Zarxio’s Suffix

27 Apr 2015

Related Companies

Novartis AG

Genentech, Inc.

Ultragenyx Pharmaceutical Inc.

Spark Therapeutics, Inc.

Additional Topics

United States Biosimilars Biologics Regulation FDA BioPharmaceutical

More from Biosimilars

More from Biosimilars & Generics

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.